# Docetaxel

NDC: 67457-781
Generic name: Docetaxel
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20190618

FDA application: ANDA208137

## Active ingredients

- DOCETAXEL: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-781"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-781
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6417655-9448-4886-ba03-f57f36bcbd14